Markey Cancer Center at Lexington Clinic Begins Providing Services
By Kristi Willett June 24, 2019
LEXINGTON, Ky. (June 24, 2019) — The Markey Cancer Center at Lexington Clinic began providing services on Monday to patients as part of an agreement between UK HealthCare and Lexington Clinic that enhances and expands outpatient cancer care throughout Central Kentucky.
Medical oncology and infusion services at 1221 South Broadway in Lexington, and oncology, infusion and radiation therapy services at 793 Eastern Bypass, Suite G2 in Richmond, are now being provided collaboratively between the two organizations. Markey Cancer Center is the only National Cancer Institute (NCI)-designated cancer center in Kentucky and one of only 70 in the nation. As part of the collaboration, patients will benefit from enhanced specialty pharmacy services, supportive treatment services, clinical trials and more.
Lexington Clinic medical oncology and radiation medicine physicians and their advanced practice providers will continue to provide services as part of the Markey Cancer Center at Lexington Clinic. Patients who already have been receiving care at one of the Lexington Clinic sites will continue to see their same physicians and providers. In addition, patients needing advanced cancer care or those that may benefit from clinical trials may also be provided treatment at the Markey Cancer Center on the UK campus.
"Just a few short months ago negotiations and discussions began between UK HealthCare and Lexington Clinic and due to the desire to combine our strengths to provide the best cancer care to Central Kentuckians, we are elated to have reached this milestone," said Dr. Mark F. Newman, UK executive vice president for health affairs.
UK HealthCare is focused on bolstering its outpatient services in critical clinical areas such as cancer. The relationship with Lexington Clinic expands the number of patients who could participate in clinical trials, crucial to the development of new drugs and therapies at the Markey Cancer Center. It also creates opportunities to boost UK’s tripartite mission of excellence in research, education and clinical care within the Bluegrass.
“Lexington Clinic is thrilled to begin offering cancer services in collaboration with UK HealthCare and Markey Cancer Center. Our commitment is, and has always been, to perfect the patient experience and provide the best care possible. We believe this collaboration positions us to expand our services and reach to help the people of Central Kentucky," said Dr. Andrew H. Henderson, Lexington Clinic CEO.
Founded in 1920, Lexington Clinic is a community-focused provider and the largest independent multi-specialty group in Kentucky with more than 200 providers in 30 different specialties. The group sees more than 1,000 new cancer patients every year.
ABOUT MARKEY CANCER CENTER — The University of Kentucky Markey Cancer Center was founded in 1983 and is a dedicated matrix cancer center established as an integral part of the University of Kentucky and the UK HealthCare enterprise. As Kentucky’s only NCI-designated Cancer Center, the UK Markey Cancer Center’s longstanding mission is to reduce cancer incidence and mortality in the Commonwealth. Markey’s plan to improve Kentucky’s significant cancer burden is implemented through a comprehensive program of cancer research, treatment, education, prevention, and community engagement. ABOUT LEXINGTON CLINIC — Lexington Clinic was founded in 1920 and is Central Kentucky’s oldest and largest group practice. Lexington Clinic has more than 200 providers and serves more than 600,000 patients every year. Lexington Clinic has providers in 30 different specialties and has more than 25 locations throughout Central Kentucky. For more information about Lexington Clinic, please visit LexingtonClinic.com or you can follow us on Facebook.